A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 26
[Display Entries]
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : FPD
Long Form : field potential duration
No. Year Title Co-occurring Abbreviation
2019 Assessment of Proarrhythmic Potential of Drugs in Optogenetically Paced Induced Pluripotent Stem Cell-Derived Cardiomyocytes. CiPA, iPSC-CMs
2019 Electrophysiological evaluation of pentamidine and 17-AAG in human stem cell-derived cardiomyocytes for safety assessment. hERG, hERG-CHOs, hES-CMs, Hsp90, MEA, TdP
2019 Pretreatment with neuregulin-1 improves cardiac electrophysiological properties in a rat model of myocardial infarction. CV, FP, ISI, MI, NRG-1, rhNRG, SO, VA
2019 Scaling and correlation properties of RR and QT intervals at the cellular level. ECGs, hiPSC-CM, IBI
2019 Sex-Related Differences in Drug-Induced QT Prolongation and Torsades de Pointes: A New Model System with Human iPSC-CMs. hiPSC-CMs, iPSC, TdP
2018 On-chip spatiotemporal electrophysiological analysis of human stem cell derived cardiomyocytes enables quantitative assessment of proarrhythmia in drug development. CT, hESC-CMs, MEA
2018 Proarrhythmia risk prediction using human induced pluripotent stem cell-derived cardiomyocytes. FPDcF, hiPSC-CMs, MEA
2017 Assessment of acute and chronic toxicity of doxorubicin in human induced pluripotent stem cell-derived cardiomyocytes. hiPSC-CMs, MEA
2017 Assessment of extracellular field potential and Ca2+ transient signals for early QT/pro-arrhythmia detection using human induced pluripotent stem cell-derived cardiomyocytes. BP, EFTPC, LL, TTC
10  2017 CSAHi study: Detection of drug-induced ion channel/receptor responses, QT prolongation, and arrhythmia using multi-electrode arrays in combination with human induced pluripotent stem cell-derived cardiomyocytes. FPDc, hiPSC-CMs, MEA
11  2017 Development of correction formula for field potential duration of human induced pluripotent stem cell-derived cardiomyocytes sheets. hiPSC-CMs
12  2017 Evaluation of Batch Variations in Induced Pluripotent Stem Cell-Derived Human Cardiomyocytes from 2 Major Suppliers. BR, iPSC-hCMs
13  2017 Frequency-dependent drug screening using optogenetic stimulation of human iPSC-derived cardiomyocytes. FP
14  2017 Recapitulation of Clinical Individual Susceptibility to Drug-Induced QT Prolongation in Healthy Subjects Using iPSC-Derived Cardiomyocytes. hiPSC-CMs, hiPSCs, MOX, SAE
15  2016 CSAHi study: Evaluation of multi-electrode array in combination with human iPS cell-derived cardiomyocytes to predict drug-induced QT prolongation and arrhythmia--effects of 7 reference compounds at 10 facilities. FPDc, FPDc10, hiPS-CMs, MEA
16  2016 Electrophysiological Characteristics of Human iPSC-Derived Cardiomyocytes for the Assessment of Drug-Induced Proarrhythmic Potential. ECG, hiPSC-CMs, MEA, TdP
17  2016 Multi-parametric assessment of cardiomyocyte excitation-contraction coupling using impedance and field potential recording: A tool for cardiac safety assessment. CiPA, FP, hiPSC-CMs, IMP, TdP
18  2015 High-throughput cardiac safety evaluation and multi-parameter arrhythmia profiling of cardiomyocytes using microelectrode arrays. hiPS-CM, MEAs
19  2015 Proarrhythmia Risk Assessment in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes Using the Maestro MEA Platform. BR, EAD, hiPSC-CM, MEA, MEC, SC-CM, TdP
20  2014 Availability of human induced pluripotent stem cell-derived cardiomyocytes in assessment of drug potential for QT prolongation. EAD, hiPS-CMs, TdP
21  2014 On-chip in vitro cell-network pre-clinical cardiac toxicity using spatiotemporal human cardiomyocyte measurement on a chip. ---
22  2012 A novel method of selecting human embryonic stem cell-derived cardiomyocyte clusters for assessment of potential to influence QT interval. ---
23  2012 Disease characterization using LQTS-specific induced pluripotent stem cells. EB, HEK, iPSCs, LQTS, MEA
24  2011 Adult human heart slices are a multicellular system suitable for electrophysiological and pharmacological studies. CV, MEA
25  2010 Prediction of drug-induced cardiotoxicity using human embryonic stem cell-derived cardiomyocytes. hERG, hESC-CM, TdP
26  2007 Effect of cardioactive drugs on action potential generation and propagation in embryonic stem cell-derived cardiomyocytes. MEA